Success of EU's New Research Infrastructure Strategy in Jeopardy Because of Disjointed Funding

Success of EU’s New Research Infrastructure Strategy in Jeopardy Because of Disjointed Funding


The European Commission has introduced a novel, comprehensive strategy centered on research and technology infrastructures (RTIs), underscoring their essential function in promoting scientific innovation throughout Europe. These infrastructures comprise shared laboratories, technology platforms, and essential research facilities.

Europe is home to more than 100 such infrastructures, which are pivotal in advancing science and technology across the continent. Research infrastructures (RIs) include cutting-edge equipment, laboratories, and digital assets, which can exist as individual sites, like the European Synchrotron Radiation Facility in Grenoble; multi-site networks, such as the European Molecular Biology Laboratory (EMBL); or virtual networks like EBrains, the European neuroscience research network. Conversely, technology infrastructures (TIs) are committed to developing, testing, and scaling new technologies through pilot plants and demonstration sites, exemplified by Finland’s Bioruukki testing centre.

The European Commission has recognized significant challenges that RTIs face, primarily their fragmented and isolated operations, which result in inefficiencies and restricted accessibility. Furthermore, regional disparities frequently hinder the equal distribution of benefits from innovative facilities. Funding poses a substantial obstacle, as RTIs depend on a mix of regional, national, and European Union (EU) sources that often lack long-term stability. Horizon Europe’s existing programme, which continues until 2027, designates €2.4 billion for RIs and a lesser €21.5 million for TIs from 2025 to 2027, while EU structural funds also provide additional financial support.

The commission’s strategy emphasizes the urgent need for coordinated investments and resource consolidation to prevent duplication, enhance governance, and ensure long-term sustainability. It seeks to promote cross-border collaboration and equitable access, particularly for startups and small to medium enterprises (SMEs), while also aiming to retain top talent and strengthen Europe’s international partnerships.

Addressing the funding gap is crucial, with the commission advocating for a €10.9 billion budget for the Horizon Europe successor programme beginning in 2028, in which 20% of new RIs’ expenses would be supported by EU funds. However, a study conducted by the European Investment Bank indicates that TIs alone will require between €13 billion and €16 billion by 2030. The report emphasizes the dependence on public funding and the need to draw industrial interest for operational viability.

The European Association of Research and Technology Organisations (EARTO) perceives the strategy as a transformative move for RTIs in Europe, though it points out that the commission’s suggested budget remains inadequate. Effective collaboration across diverse funding programs and ongoing investment coordination, including from the European Competitiveness Fund, is vital for achieving coherent and impactful investments.

For organizations like EMBL, the EU’s strategic vision emphasizes RTIs’ crucial role as foundations of European science and competitiveness. Achieving success will depend on the execution of the strategy, which will require innovative funding mechanisms, strong public-private partnerships, long-term policy dedication, and alignment with the needs of the scientific community. Turning ambitious objectives into practical support for RTIs remains a priority for Europe to sustain its advantage in global research and innovation.